Correlation Between Brookfield and Cannara Biotech

Can any of the company-specific risk be diversified away by investing in both Brookfield and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brookfield and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Brookfield and Cannara Biotech, you can compare the effects of market volatilities on Brookfield and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brookfield with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brookfield and Cannara Biotech.

Diversification Opportunities for Brookfield and Cannara Biotech

0.53

Correlation Coefficient

Brookfield  Cannara Biotech

Very weak diversification

The 3 months correlation between Brookfield and Cannara is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Brookfield and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Brookfield is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brookfield are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Brookfield i.e., Brookfield and Cannara Biotech go up and down completely randomly.

Pair Corralation between Brookfield and Cannara Biotech

Assuming the 90 days trading horizon Brookfield is expected to generate 0.11 times more return on investment than Cannara Biotech. However, Brookfield is 9.52 times less risky than Cannara Biotech. It trades about 0.26 of its potential returns per unit of risk. Cannara Biotech is currently generating about -0.01 per unit of risk. If you would invest  2,351  in Brookfield on September 25, 2024 and sell it today you would earn a total of  99.00  from holding Brookfield or generate 4.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Brookfield  vs.  Cannara Biotech

Brookfield

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Brookfield are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Brookfield may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cannara Biotech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Brookfield and Cannara Biotech

The main advantage of trading using opposite Brookfield and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brookfield position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.

The idea behind Brookfield and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.